Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (10,247,133)	$ (38,043,362)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,249,194	1,653,819
Amortization of loan discount and fees	3,937,007	6,506,384
Loss on extinguishment of debt	716,517
Loss on disposition of business	1,523,940
Stock-based compensation	408,810	602,038
Shares issued for services	1,656,428
Change in credit reserve	202,761	(118,840)
Change in fair value of contingent consideration	(10,698,475)	564,303
Deferred tax expense	368,034
Deferred offering costs		367,696
Fees incurred in connection with debt financings		568,149
Change in fair value of warrant liability		(18,223)
Change in fair value of derivative liability		(1,354,434)
Impairment of goodwill and intangible assets		5,503,095
Loss from discontinued operations, net of tax		10,928,643
Forgiveness of Payroll Protection Program		(1,760,755)
Changes in operating assets and liabilities:
Accounts receivable, net	497,771	(452,030)
Due from factor, net	144,755	655,708
Inventory	375,682	479,394
Prepaid expenses and other current assets	551,259	(445,798)
Accounts payable	1,900	892,120
Accrued expenses and other liabilities	1,047,430	1,631,512
Deferred revenue	(183,782)
Due to related parties		298,943
Accrued interest	434,958	984,358
Assets and liabilities of discontinued operations		(210,426)
Net cash used in operating activities	(6,012,942)	(10,767,706)
Cash flows from investing activities:
Cash acquired (consideration) pursuant to business combination		(7,247,303)
Purchase of property, equipment and software	(29,675)	(61,286)
Deposits	118,494	(60,548)
Net cash provided by (used in) investing activities	88,819	(7,369,137)
Cash flows from financing activities:
Repayments of elated party advances	(155,205)
Advances (repayments) from factor	154,073	(3,096)
Repayment of contingent consideration		(645,304)
Proceeds from venture debt		237,500
Issuance of loans and note payable	5,479,611	3,280,360
Repayments of convertible and promissory notes	(10,129,811)	(7,350,276)
Issuance of convertible notes payable		6,951,250
Proceeds from public offering		19,347,446
Offering costs		(2,921,216)
Issuance of common stock, net of offering costs	8,145,381
Proceeds from exercise of warrants	1,167,566
Net cash provided by financing activities	4,661,614	18,896,664
Net change in cash and cash equivalents	(1,262,509)	759,820
Cash and cash equivalents at beginning of year	1,283,282	523,462
Cash and cash equivalents at end of year	20,773	1,283,282
Less: cash of discontinued operations		7,666
Cash of continuing operations at end of year	20,773	1,275,616
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest	711,815	734,869
Supplemental disclosure of non-cash investing and financing activities:
Conversion of notes into preferred stock	5,759,177
Conversion of notes into common stock		11,983,389
Right of use asset	467,738	102,349
Warrants issued in connection with note		1,368,741
Derivative liability in connection with convertible note		559,957
Conversion of related party notes and payables into preferred and common stock		6,300,000
Conversion of venture debt into preferred stock